Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carbetocin

A long-acting synthetic agonist analogue of human oxytocin, with antihemorrhagic and uterotonic activities. Upon administration, carbetocin targets, binds to and activates peripheral oxytocin receptors that are present on the smooth musculature of the uterus. This causes uterus contractions and prevents excessive bleeding after childbirth, particularly following Cesarean section, and may be used to decrease blood loss during hysteroscopic myomectomy.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Pabal
Chemical structure:1-butyric acid-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin
1-carboxytocin, 1-butanoic acid-2-(O-methyl-L-tyrosine)-
1-deamino-1-monocarba-(0-2-methyltyrosine)-oxytocin
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search